SMSLIFE.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 18:59):

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India...

Stats
本日の出来高	500.00
平均出来高	6 192.00
時価総額	2.00B
EPS	INR0 ( 2024-02-10 )
次の収益日	( INR0 ) 2024-05-27
Last Dividend	INR1.500 ( 2023-09-22 )
Next Dividend	INR0 ( N/A )
P/E	40.81
ATR14	INR2.61 (0.39%)

ボリューム相関

長: -0.10 (neutral)

短: -0.28 (neutral)

Signal:(46.31) Neutral

SMS Lifesciences India 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

SMS Lifesciences India 相関 - 通貨/商品

0.54
( weak )

0.59
( weak )

0.54
( weak )

-0.02
( neutral )

0.42
( neutral )

-0.20
( neutral )

SMS Lifesciences India 財務諸表

Annual	2022
収益:	INR3.16B
総利益:	INR875.57M (27.75 %)
EPS:	INR37.92

FY	2022
収益:	INR3.16B
総利益:	INR875.57M (27.75 %)
EPS:	INR37.92

FY	2022
収益:	INR3.47B
総利益:	INR875.42M (25.21 %)
EPS:	INR83.61

FY	2021
収益:	INR2.57B
総利益:	INR702.13M (27.27 %)
EPS:	INR44.84

Financial Reports:

No articles found.

SMS Lifesciences India Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

SMS Lifesciences India Dividend Information - Dividend Junior

Dividend Sustainability Score: 1.887 - low (50.00%) | Divividend Growth Potential Score: 4.08 - Stable (18.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.500	2019-09-19
Last Dividend	INR1.500	2023-09-22
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR6.00	--
Avg. Dividend % Per Year	0.14%	--
Score	1.19	--
Div. Sustainability Score	1.887
Div.Growth Potential Score	4.08
Div. Directional Score	2.98	--

Next Divdend (Est)
(2024-12-09)

INR1.512 Estimate 2.94 %

Dividend Stability

0.24 Very Poor

Dividend Score

1.19

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2019	INR1.500	0.31%
2020	INR0	0.00%
2021	INR1.500	0.24%
2022	INR1.500	0.20%
2023	INR1.500	0.24%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SPAL.NS	Dividend Junior	2023-09-15	Sporadic	8	0.44%
MOTHERSON.NS	Dividend Junior	2023-08-11	Annually	23	0.63%
HERITGFOOD.NS	Dividend Junior	2023-08-14	Annually	23	0.44%
BIKAJI.NS	Dividend Junior	2023-06-08	Insufficient data to determine frequency	2	0.06%
RANEHOLDIN.NS	Dividend Junior	2023-07-27	Annually	21	0.95%
KOPRAN.NS	Dividend Junior	2023-09-07	Annually	5	1.18%
ESCORTS.NS	Dividend Junior	2023-06-30	Annually	28	0.21%
ALPHAGEO.NS	Dividend Junior	2023-09-22	Annually	18	2.07%
SYMPHONY.NS	Dividend Knight	2023-08-04	Semi-Annually	14	0.47%
NESCO.NS	Dividend Junior	2023-07-28	Annually	17	0.40%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0175	1.500	9.65	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0278	1.500	-0.802	-1.203	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	1.171	1.000	-0.677	-0.677	[3 - 30]
operatingCashFlowPerShareTTM	93.14	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	93.14	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.248	1.000	9.19	9.19	[0.2 - 0.8]
operatingProfitMarginTTM	0.0382	1.000	-1.236	-1.236	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				1.887

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	40.60	1.000	6.00	0	[1 - 100]
returnOnEquityTTM	0.0278	2.50	-0.516	-1.203	[0.1 - 1.5]
freeCashFlowPerShareTTM	93.14	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.228	1.500	4.29	0	[0 - 0.4]
operatingCashFlowPerShareTTM	93.14	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.468	1.500	-0.215	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.101	1.000	9.98	0	[0.1 - 0.5]
Total Score				4.08

SMS Lifesciences India

SMS Lifesciences India Limited manufactures, buys, imports, and sells active pharmaceutical ingredients (API) and its intermediates, organic and inorganic chemicals, and pharmaceuticals in India. The company offers APIs in various therapeutic areas, such as antiulcer, antifungal, and erectile dysfunction. It also provides consultancy services. The company exports its products. The company was founded in 1990 and is based in Hyderabad, India.